Amid mounting tension over drug costs, AbbVie takes aim at Canadian gray goods
AbbVie is urging a US court to reject claims by a trademark defendant that there can be no likelihood of confusion when consumers are informed their medicines have been sourced abroad....To view the full article, register now.
Already a subscriber? Click here to view full article